BAMCO Inc’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,023,663
Closed -$2.63M 346
2024
Q2
$2.63M Hold
1,023,663
0.01% 282
2024
Q1
$5.04M Hold
1,023,663
0.01% 268
2023
Q4
$9M Buy
1,023,663
+3,429
+0.3% +$28.1K 0.02% 241
2023
Q3
$11.7M Sell
1,020,234
-102,432
-9% -$1.97M 0.03% 228
2023
Q2
$28.4M Buy
1,122,666
+53,183
+5% +$1.66M 0.08% 173
2023
Q1
$34.4M Sell
1,069,483
-188,225
-15% -$5.87M 0.1% 153
2022
Q4
$23.2M Sell
1,257,708
-462,800
-27% -$10.6M 0.08% 170
2022
Q3
$46.5M Buy
1,720,508
+37,500
+2% +$761K 0.15% 118
2022
Q2
$23.3M Buy
1,683,008
+290,600
+21% +$4.47M 0.07% 191
2022
Q1
$27.2M Hold
1,392,408
0.07% 200
2021
Q4
$22.7M Hold
1,392,408
0.05% 250
2021
Q3
$38.8M Buy
1,392,408
+258,476
+23% +$7.38M 0.09% 199
2021
Q2
$33.6M Buy
1,133,932
+42,200
+4% +$1.22M 0.08% 198
2021
Q1
$30.5M Buy
1,091,732
+350,000
+47% +$9.68M 0.08% 187
2020
Q4
$21M Buy
741,732
+160,000
+28% +$4.14M 0.05% 212
2020
Q3
$14.6M Hold
581,732
0.04% 214
2020
Q2
$14.2M Buy
581,732
+75,000
+15% +$1.48M 0.05% 196
2020
Q1
$7.5M Sell
506,732
-321,000
-39% -$6.64M 0.04% 210
2019
Q4
$13.4M Hold
827,732
0.05% 193
2019
Q3
$10.8M Buy
827,732
+192,532
+30% +$2.36M 0.04% 200
2019
Q2
$8.24M Buy
635,200
+126,000
+25% +$1.59M 0.03% 233
2019
Q1
$8.03M Buy
+509,200
New +$8.83M 0.03% 220
2015
Q2
Sell
-30,000
Closed -$622K 365
2015
Q1
$622K Sell
30,000
-13,000
-30% -$225K ﹤0.01% 344
2014
Q4
$728K Hold
43,000
﹤0.01% 334
2014
Q3
$831K Buy
43,000
+23,000
+115% +$599K ﹤0.01% 330
2014
Q2
$680K Buy
20,000
+2,500
+14% +$78.3K ﹤0.01% 320
2014
Q1
$551K Buy
+17,500
New +$547K ﹤0.01% 328

Other funds holding RVNC